(Q33948758)

30 July 2017

1 reference

title

New developments and approaches in the platinum arena (English)

1 reference

30 July 2017

1 reference

Judson I

1

1 reference

PubMed ID

10864228

30 July 2017

Kelland LR

series ordinal

2

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

59 Suppl 4

1 reference

30 July 2017

29-36; discussion 37-8

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059004-00004

30 July 2017

0 references

cites work

A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system

1 reference

12 December 2020

1,2-Diaminocyclohexane platinum derivatives of potential clinical value.

1 reference

12 December 2020

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen

1 reference

12 December 2020

Oxaliplatin: a review of preclinical and clinical studies.

1 reference

12 December 2020

Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).

1 reference

12 December 2020

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug

1 reference

12 December 2020

A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Prolonged remission of endometrial cancer with paclitaxel and carboplatin

1 reference

12 December 2020

Concurrent platinum-based chemo- and radiotherapy for locally advanced cervical cancer: a new gold-standard treatment?

1 reference

12 December 2020

Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group

1 reference

12 December 2020

Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery

1 reference

12 December 2020

DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent

1 reference

12 December 2020

cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.

1 reference

12 December 2020

Preclinical perspectives on platinum resistance

1 reference

12 December 2020

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

1 reference

12 December 2020

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.

1 reference

12 December 2020

Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer

1 reference

12 December 2020

A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration

1 reference

12 December 2020

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

12 December 2020

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

12 December 2020

Chemotherapy of advanced ovarian cancer

1 reference

12 December 2020

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

12 December 2020

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

12 December 2020

Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.

1 reference

12 December 2020

Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation

1 reference

12 December 2020

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

1 reference

12 December 2020

Phase I study of oral JM216 given twice daily

1 reference

12 December 2020

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)

1 reference

12 December 2020

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial

1 reference

12 December 2020

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group

1 reference

12 December 2020

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

1 reference

12 December 2020

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin

1 reference

12 December 2020

The clinical pharmacology of paclitaxel (Taxol).

1 reference

12 December 2020

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

1 reference

12 December 2020

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

1 reference

12 December 2020

Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin

1 reference

12 December 2020

10.2165/00003495-200059004-00004

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10864228